mRNA |
QW-BI-011 |
CTRPv2 |
pan-cancer |
AAC |
0.032 |
0.6 |
mRNA |
SZ4TA2 |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.6 |
mRNA |
C6-ceramide |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
masitinib |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
GMX-1778 |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
Bryostatin 1 |
GDSC1000 |
pan-cancer |
AAC |
-0.016 |
0.6 |
mRNA |
A-770041 |
GDSC1000 |
pan-cancer |
AAC |
0.025 |
0.6 |